Search

everythinglearnresearchcommunity

for

Search:↓

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Females generally have stronger immune responses than males due to the X chromosome.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Long COVID symptoms are linked to immune issues, poor blood flow, and lung problems.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

A rare case links early-onset alopecia universalis and nephrotic syndrome, suggesting genetic immune issues.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

3D spheroid culture makes stem cells better at reducing inflammation.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

Hair loss condition FFA was seen before the appearance of skin depigmentation vitiligo in a patient.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

DM and AA may share a common cause.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Rapid thawing increases tissue destruction and tumor growth inhibition.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Certain genetic changes in the STX17 and KRT82 genes contribute to hair loss in alopecia areata.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.